Amphastar names Anthony Pierce to board as director expands to 11 seats
AMPH•Board expansion and new director appointment
- Amphastar Pharmaceuticals expanded its board to 11 directors on July 9, 2026.
- Anthony Pierce joined as a Class III director, serving until the 2028 annual meeting.
- Pierce was not assigned to any board committees at the time of his appointment.
Related News
Kamada says CYTOGAM study links CMV immunoglobulin prophylaxis to improved outcomes in high-risk lung transplant patients
KMDA•
Adlai Nortye adds MD Anderson’s David Hong, MSK’s Piro Lito to scientific advisory board
ANL•
